Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subtype of Waardenburg syndrome type 4 (Waardenburg-Shah syndrome) caused by mutations in EDNRB.
Features include: Heterochromia iridis, White forelock, Polyneuropathy, and Global developmental delay and 12 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Polyneuropathy, Global developmental delay, Ataxia |
Muscles |
EDNRB encodes endothelin receptor type B (442 aa). Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system Highest expression in Adipose Visceral Omentum (73.2 TPM) and Lung (65.4 TPM).
Waardenburg syndrome type 4A has been associated with mutations in the EDNRB gene on chromosome 13.
The EDNRB protein participates in EDNRA, EDNRB bind non-selective ERAs, EDNRA,EDNRB bind EDNs, and MITF gene expression pathways.
EDNRB is classified as a druggable target (Druggable Genome and G Protein Coupled Receptor categories) with score 3.7.
Genetic testing for EDNRB is available. Testing is considered supportive for diagnosis.
Biomarker and diagnostic research for Waardenburg syndrome type 4A has been reported in the published literature.
No clinical trials have been registered for Waardenburg syndrome type 4A.
14 publications have been identified in PubMed for Waardenburg syndrome type 4A. Research spans Case Report / Case Series (43%), Review / Meta-Analysis (29%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 43% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Waardenburg syndrome type 4A
1
Low muscle tone (hypotonia) |
Skin | 1 | Hypopigmented skin patches |
Eyes | 1 | Nystagmus |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
4 |
29% |
Laboratory research | 2 | 14% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Liu D (2026). [PMID: 41668496](https://pubmed.ncbi.nlm.nih.gov/41668496/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Case Report / Case Series]
Mahoney K (2026). [PMID: 41795619](https://pubmed.ncbi.nlm.nih.gov/41795619/). *Am J Med Genet A*. [Review / Meta-Analysis]
Bharadwaj T (2025). [PMID: 40371963](https://pubmed.ncbi.nlm.nih.gov/40371963/). *Clin Genet*. [Epidemiology / Natural History]
Ersson B (2025). [PMID: 40364458](https://pubmed.ncbi.nlm.nih.gov/40364458/). *Neurogastroenterol Motil*. [Case Report / Case Series]
Aboagye ET (2025). [PMID: 41516007](https://pubmed.ncbi.nlm.nih.gov/41516007/). *Int J Mol Sci*. [Review / Meta-Analysis]
Takeuchi M (2025). [PMID: 40627393](https://pubmed.ncbi.nlm.nih.gov/40627393/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Poon JYY (2025). [PMID: 40702859](https://pubmed.ncbi.nlm.nih.gov/40702859/). *Am J Med Genet A*. [Review / Meta-Analysis]
Gombojav B (2025). [PMID: 40650035](https://pubmed.ncbi.nlm.nih.gov/40650035/). *Int J Mol Sci*. [Case Report / Case Series]
Cagan Appak Y (2025). [PMID: 32967600](https://pubmed.ncbi.nlm.nih.gov/32967600/). *Exp Clin Transplant*. [Case Report / Case Series]
Tan J (2025). [PMID: 39868048](https://pubmed.ncbi.nlm.nih.gov/39868048/). *iScience*. [Basic Science / Preclinical]